Skip to main content
ECVT logo

ECVT · Ecovyst Inc.

Track ECVT — free
$10.55 -0.01 (-0.09%)
Market Cap
$1.15B
Shares
108.62M
Volume · Nov 17 53.79K Avg daily vol (3M) 1.34M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$10.56 Open$10.97 Day$10.52–10.99 52W close$8.14–14.97 Avg vol 30d1.4M Short int6.6M · 6.1% of shares · 4.8d Short vol48% Last earningsNov 5, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 5

Up next

Feb 25, 2027 Est · unconfirmed · in 14 wks

Latest documents

2026
Nov 5
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Sales rise 47.6% as Calabrian adds volume

For the nine months ended September 30, 2026, Ecovyst reported sales of $773.6 million, up 47.6%, gross profit of $145.0 million and operating income of $61.1 million; Calabrian contributed to higher volume.

Revenue $308.64M ▲ 50.6% Net income $18.16M Diluted EPS $0.16
Read from the MD&A section
6 source passages
references in this report to “Ecovyst,” “the Company,” “we,” “us” or “our” refer to Ecovyst Inc. and its consolidated subsidiaries. Nine Months Ended September 30, 2026 Compared to the Nine Months Ended September 30, 2025 Sales for the nine months ended September 30, 2026 were $773.6 million, an increase of $249.5 million, or 47.6%, compared to sales of $524.1 million for the nine months ended September 30, 2025. Gross profit for the nine months ended September 30, 2026 was $145.0 million, an increase of $33.6 million, or 30.2%, compared to $111.4 million for the nine months ended September 30, 2025. Operating income increased by $18.0 million to $61.1 million. The increase in sales volume was driven by higher sales of regenerated sulfuric acid from strong demand and less customer downtime along with higher sales of virgin sulfuric acid due to increased customer demand and the contribution of sales volume from the Waggaman location and the recently acquired Calabrian business. Open the document at this passage
Nov 5
Earnings call
Adjusted EBITDA guidance raised to $208 to $212 million

Ecovist raised full-year 2026 adjusted EBITDA guidance to $208 to $212 million after third-quarter sales reached $309 million and adjusted EBITDA reached $61 million. It also lifted adjusted free cash flow guidance to $50 million to $60 million.

5 source passages
Welcome to the Ecovist third quarter, 2026 earnings call and webcast. Third quarter sales were $309 million, up $104 million, or 51%, compared to the year-ago quarter. Adjusted EBITDA of $61 million was up over 6%, reflecting the volume and pricing dynamics contributing to the sales increase. We are now raising our full-year 2026 adjusted EBITDA guidance to a range of $208 million to $212 million, a 4.5% increase at the midpoint from our prior guidance range of $195 to $207 million. We are also raising our adjusted free cash flow guidance to a range of $50 million to $60 million, up from $45 to $55 million. Open the document at this passage
Nov 5
Current report 8-K
Third-quarter sales rose 51%; full-year EBITDA outlook raised

Ecovyst reported third-quarter sales of $308.6 million, up 51%, and Adjusted EBITDA of $61.2 million, up 6%, as it raised 2026 Adjusted EBITDA guidance to $208 million to $212 million.

Financial results
4 source passages
Ecovyst Reports Third Quarter 2026 Results and Raises 2026 Outlook Sales grew 51% to $308.6 million, an increase of $103.7 million, from $204.9 million in the third quarter of 2025 Adjusted EBITDA1 of $61.2 million, an increase of $3.7 million, or 6% compared to $57.5 million in the third quarter of 2025 We are again raising our full-year Adjusted EBITDA guidance to a range of $208 million to $212 million, reflecting strong momentum through the first nine months of the year and the shift of a turnaround from the fourth quarter into early 2027 Open the document at this passage
Oct 28
Current report 8-K Events of Oct 22
Director or officer change, or executive pay

Ecovyst Inc. approved its Second Amended and Restated Severance Plan effective October 22, 2026, providing executive officers 52 weeks of Compensation and the CEO 104 weeks. Change-in-control severance is 18 months for non-CEO officers and 30 months for the CEO.

Read from the first part of this long document
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$972.98M
Trailing 12 months
Net income (TTM)
$36.08M
Trailing 12 months
Revenue growth YoY
+50.6%
Year over year
Operating margin
8.5%
Trailing 12 months
P / E (TTM)
34.3
Trailing earnings · reciprocal yield 2.9%
FCF yield
2.3%
TTM · current market cap
Return on invested capital
6.4%
Trailing 12 months
Net cash
−$421.94M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-3.7%
Year over year · fewer shares
Price change (1Y)
+23.4%
Trailing year
Short interest
6.1%
Latest settlement · 4.8 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Nov 5, 2026
Q3 FY26

TL;DR. Ecovyst delivered strong third-quarter sales and earnings growth, raised full-year sales, Adjusted EBITDA, Adjusted Free Cash Flow and adjusted earnings guidance, and expects positive demand with Calabrian integration and synergies on track. Offsets included lower margins, higher costs, weaker nine-month Adjusted Free Cash Flow, higher net leverage, expected lower fourth-quarter virgin acid volume, increased spending and depreciation guidance, and outage and destocking risks.

Bullish
  • + Demand is expected to remain positive, supported by high refinery utilization, strong alkylate demand, copper mining and Canadian gold mine operating rates. new
  • + Calabrian integration and the delivery of expected synergies remain on track. new
  • + A turnaround previously planned for the fourth quarter was deferred to early 2027, reducing expected 2026 cost by approximately $3 million. new
Bearish
  • − Nine-month Adjusted Free Cash Flow declined to $32.4 million from $42.4 million, reflecting higher capital expenditures and sulfur-related working-capital use. new
  • − Fourth-quarter virgin sulfuric acid volume is expected to be lower than in the prior-year quarter. new
  • − Unplanned refining outages and potential customer destocking remain outlook risks. new

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Strong Quant / Vol Moderate
Market backdrop VIX 22.9 · elevated Equity put/call 0.73
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg −10%
below
Price vs 50-day avg +3%
above
RSI (14) 55
neutral
MACD trend Positive
52-week position 35%
mid-range
Momentum
relative strength
Neutral
1-month return +4%
trailing
6-month return −24%
trailing
YTD return +9%
this year
Relative strength −23%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $10 › 200d $12 — 200d above 50d
Institutional flow Distributing
-4% holders QoQ · +29 funds added
Insider flow Accumulating
Net +$250.0K over 90 days · 0% sells
Short interest Rising
6.09% of shares out · ▲ +4.5% MoM · 4.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
201 holders — mid 3-yr range
Squeeze score 62
elevated · 0–100
Fundamentals
Strong
Revenue growth +21%
Y/Y
Gross margin 22%
contracting
EPS growth −917%
Y/Y
Free cash flow $69.9M
Valuation P/E 33
in line
Buyback $143.8M
remaining
Balance sheet $195.4M
net debt
Quant / Vol
risk profile
Moderate
Volatility 32%
annualized · 1-yr
Max drawdown −35%
past year
ATR 3.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 2 of last 8
Latest guidance · from the 8-K filed Nov 5, 2026
2026
Adjusted EBITDA Non-GAAP Raised $208M – $212M
May 5, 2026 $180M – $195M changed to Nov 5, 2026 $208M – $212M
Adjusted Free Cash Flow Non-GAAP Raised $50M – $60M
May 5, 2026 $40M – $55M changed to Nov 5, 2026 $50M – $60M
Capital expenditures Raised $90M – $95M
Aug 5, 2026 $85M – $95M changed to Nov 5, 2026 $90M – $95M
Interest expense Maintained $19M – $21M
Aug 5, 2026 $18M – $22M changed to Nov 5, 2026 $19M – $21M
Depreciation & Amortization Raised $84M – $88M
Aug 5, 2026 $80M – $84M changed to Nov 5, 2026 $84M – $88M
Adjusted Net Income Non-GAAP Raised $70M – $85M
Aug 5, 2026 $65M – $85M changed to Nov 5, 2026 $70M – $85M
Sales Raised $1.05B – $1.07B
Aug 5, 2026 $1.02B – $1.06B changed to Nov 5, 2026 $1.05B – $1.07B
prior FY $723.52M midpoint +46.5% Y/Y
second half of 2026
Repurchase up to $20M
Previous outlook earlier release · from the 8-K filed May 5, 2026

Still-open targets the latest release did not restate under the same label.

Adjusted Diluted Income per share · 2026 $0.50 – $0.65
Prior guidance period ended · from the Earnings Call filed May 5, 2026
Adjusted EBITDA · second quarter 2026 $50M – $55M
Adjusted EBITDA · third quarter 2026 $50M – $55M
Guided vs delivered · last 8 settled
Sales full year 2025
guided $795M – $835M
$723.52M Miss −11.2%
Sales full year 2024
guided $700M – $740M
$598.3M Miss −16.9%
Sales full year 2023
guided $675M – $705M
$584.85M Miss −15.2%
Sales 2022 financial outlook
guided $810M – $830M
$820.16M In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−10% Bearish
Price vs 50-day avg
+3% Bullish
RSI (14)
55 Neutral
MACD trend
Positive Bullish
52-week position
35% Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $10 › 200d $12 — 200d above 50d
Institutional flow Distributing
-4% holders QoQ · +29 funds added
Insider flow Accumulating
Net +$250.0K over 90 days · 0% sells
Short interest Rising
6.09% of shares out · ▲ +4.5% MoM · 4.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
201 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $8 Now $11 · 35% Range high $15
vs 200-day avg -10% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted Diluted Income per share non-GAAP $0.21 second quarter 2026 —
Adjusted EBITDA non-GAAP $53.1M second quarter 2026 —
Adjusted EBITDA from continuing operations non-GAAP $201.7M Trailing twelve months ended June 30, 2026 —
GAAP → non-GAAP reconciliation
GAAP Net income from continuing operations $25.8M
+$27.5M Provision for income taxes
+$24.1M Interest expense, net
+$81.5M Depreciation and amortization
+$5.6M Debt modification and extinguishment costs
+$7.7M Net loss on asset disposals
+$10.5M Transaction and other related costs
+$10.3M Equity-based compensation
+$4.8M Restructuring, integration and business optimization expenses
+$3.9M Other
= Adjusted EBITDA from continuing operations $201.7M
Adjusted EBITDA from continuing operations margin non-GAAP 21.2% Three months ended June 30, 2026 —
Adjusted Free Cash Flow non-GAAP $12.8M six months ended June 30, 2026 —
Adjusted Net Income non-GAAP $35.6M Six months ended June 30, 2026 —
Free Cash Flow non-GAAP $6.5M Six months ended June 30, 2026 —
Net debt $409.3M June 30, 2026 —
Net Debt Leverage Ratio 2 June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Specialty Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ECVT
Ecovyst Inc.
this stock
$1.15B +8.5% +20.9% 33.0 6.1%
LIN
Linde PLC
$240.31B +22.8% +3.0% 34.7 1.4%
AIQUF
L Air Liquide SA
$135.80B +13.3% — — 0.0%
ECL
Ecolab Inc.
$86.50B +17.5% +2.2% 42.0 1.5%
SHW
Sherwin Williams Co
$84.69B +8.2% +2.1% 32.3 2.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
201
% held
103.5%
Net QoQ
+2.6M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
265
View
Short & Settlement
Short Interest Rising
Shares short
6.6M
Days to cover
4.8d
Change
+285.9K sh
View
Short Volume
Short vol %
48%
As of
Nov 16, 2026
Short Total
View
Fails to Deliver
FTD shares
62
Value
$635
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
37.5%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$250.0K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$723.5M
Net income (FY)
$-71.1M
EPS diluted
$-0.61
View
Buybacks
Authorized
$450.0M
Remaining
$143.8M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 5, 2026
This year
16

For the nine months ended September 30, 2026, Ecovyst reported sales of $773.6 million, up 47.6%, gross profit of $145.0 million and operating income of $61.1 million; Calabrian contributed to higher volume.

View
Proposed Sales
Value
$385.5K
Shares
29.9K
Filed
Jul 17, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 5, 2026
View
Investor Relations
Latest news
Ecovyst Reports Third Quarter 202…
Published
Nov 5, 2026
View

Performance

5D 20D 120D MTD YTD
ECVT -1.9% +4.2% -24.4% +4.4% +8.5%
SPY -1.7% -3.5% -1.4% -2.1% +8.5%
vs SPY -0.2% +7.7% -23.0% +6.4% +0.0%

Capital returns

Latest dividend
$3.20 / share · ex Aug 11, 2021
Raised 77.8%
Paid (TTM)
$0.00 / share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
$450.00M
Spent (derived)
$306.22M
Remaining
$143.78M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1708035 CUSIP 27923Q109 13F (30d) 207 filings 189 filers Visit website Investor relations